Patent ID: 8895067
Filing Date: 2014-11-25
Classification: A61K,A61P,B82Y,Y02A,Y10S

Abstract:
1. A method for stimulating a Th1 immune response against an allergen in a subject in need of treatment by immunotherapy against said allergen, said method comprising administering to the subject a Th1 immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether and maleic anhydride (PVM/MA) copolymer, and an allergen, wherein said allergen is encapsulated inside said PVM/MA copolymer nanoparticles, wherein said allergen comprises an allergenic food or an allergenic food product extract, wherein the PVM/MA-based nanoparticles further comprise an immunostimulating agent at least partially coating the surface of said nanoparticles, and wherein the stimulation of the Th1 immune response in the subject is due to said nanoparticles based on a PVM/MA copolymer.